Penn Pharma upgrades hq and invests in inventory management system

Penn Pharma, a leading UK bioscience company, has completed the first phase of its £12m five-year expansion programme by investing £315,000 in upgrading its site at Tredegar in Wales and improving transport access. In addition, the company has invested £350,000 in a new inventory management system.

As part of sustained investment in the site, and partly backed by the Welsh Assembly Government's Single Investment Fund, Penn has extended its facilities by 2,400m2 and has completely changed the transport and delivery infrastructure at its Welsh headquarters.

"The recent developments to the site only add to our established offering," said Darren Hassey, chief operating officer at Penn Pharma. "By altering the externals of the site and moving the delivery and collection points we have in turn altered the internal factory processes, ensuring the smooth flow of people, process and materials."

The inventory management system includes realtime bar coding control, "unprecedented" levels of stock accuracy and the Penn customer portal.

"Our investment in this new customer portal not only increases product visibility for customers wishing to track their order status, materials disposition and third party courier logistics, but also further enables Penn Pharma to compete on the global stage as an exemplar of best practice," said Hassey.

The secure portal allows customers remotely to access and track their Penn Pharma product inventory and materials in transit to their final destination. It provides access to realtime inventory information concerning excipients, active pharmaceutical ingredients, packaging materials and finished products/clinical packs, 24/7, 365 days a year.